Venus Remedies Ltd
VENUSREMVenus Remedies Ltd
VENUSREM
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 15.09 | 0.68 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 40.05 | 4.70 | 0.78% |
Forecast & Ratings
Detailed Forecastfrom 1 analyst
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Venus Remedies Limited is engaged in pharmaceutical product manufacturing business. The Company provides formulations and manufactures dosage injectables.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 464.67 | 420.28 | 402.31 | 374.66 | 327.98 | 375.99 | 600.36 | 608.49 | 565.83 | 519.03 | ||||||||||
Raw Materials | 264.39 | 242.04 | 223.58 | 204.84 | 189.67 | 168.45 | 347.94 | 383.50 | 322.95 | 451.68 | ||||||||||
| Power & Fuel Cost | 3.80 | 4.01 | 4.14 | 4.29 | 4.86 | 4.73 | 4.58 | 4.71 | 5.52 | |||||||||||
| Employee Cost | 32.36 | 32.44 | 34.27 | 39.31 | 42.10 | 46.02 | 46.02 | 52.33 | 57.05 | |||||||||||
| Selling & Administrative Expenses | 65.10 | 57.56 | 78.30 | 79.41 | 54.52 | 67.15 | 95.99 | 85.54 | 92.32 | |||||||||||
| Operating & Other expenses | 9.16 | 1.06 | 9.03 | 5.09 | 7.17 | 52.33 | 8.98 | 11.98 | 17.46 | |||||||||||
EBITDA | 89.86 | 83.17 | 52.99 | 41.72 | 29.66 | 37.31 | 96.85 | 70.43 | 70.53 | 67.35 | ||||||||||
| Depreciation/Amortization | 46.00 | 41.68 | 40.26 | 33.83 | 33.98 | 32.01 | 35.28 | 33.53 | 32.30 | 32.05 | ||||||||||
| PBIT | 43.86 | 41.49 | 12.73 | 7.89 | -4.32 | 5.30 | 61.57 | 36.90 | 38.23 | 35.30 | ||||||||||
| Interest & Other Items | 41.21 | 37.98 | 34.37 | 35.43 | 25.41 | 13.34 | 13.02 | 0.48 | 0.29 | 0.21 | ||||||||||
| PBT | 2.65 | 3.51 | -21.64 | -27.54 | -29.73 | -8.04 | 48.55 | 36.42 | 37.94 | 35.09 | ||||||||||
| Taxes & Other Items | -2.51 | 1.81 | -4.56 | 3.16 | -1.15 | 1.96 | -13.21 | -4.32 | 11.36 | 14.23 | ||||||||||
| Net Income | 5.16 | 1.70 | -17.08 | -30.70 | -28.58 | -10.00 | 61.76 | 40.74 | 26.58 | 20.86 | ||||||||||
| EPS | 4.51 | 1.49 | -14.36 | -24.87 | -23.16 | -8.10 | 50.04 | 31.69 | 19.88 | 15.61 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Venus Remedies Ltd | 11.84 | 0.68 | — |
| Sun Pharmaceutical Industries Ltd | 32.45 | 4.64 | 1.00% |
| Cipla Ltd | 34.76 | 4.11 | 0.70% |
| Dr Reddy's Laboratories Ltd | 20.93 | 4.05 | 0.71% |
Price Comparison
Compare VENUSREM with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 1.11%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
VENUSREM has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 23, 2013
Dividend/Share
₹3.00
Ex DateEx Date
Sep 23, 2013
Cash Dividend
Ex DateEx DateSep 20, 2012
Dividend/Share
₹3.00
Ex DateEx Date
Sep 20, 2012
Cash Dividend
Ex DateEx DateSep 22, 2011
Dividend/Share
₹3.00
Ex DateEx Date
Sep 22, 2011
Cash Dividend
Ex DateEx DateSep 23, 2010
Dividend/Share
₹3.00
Ex DateEx Date
Sep 23, 2010
News & Opinions
Venus Remedies launches flagship R&D drug Elores in Oman
1 month ago•Economic Times
Venus Remedies gets market authorisations for cancer drugs from Philippines, Praguay, Georgia, Moldova
1 month ago•Moneycontrol
Venus Remedies stops trading as sharp rally triggers enhanced surveillance measures by Sebi
2 months ago•Moneycontrol
Venus Remedies jumps 3% on nod to operate in 4 foreign markets
2 months ago•Moneycontrol
Venus Remedies gets marketing approval from different countries for chemotherapy drugs
2 months ago•Moneycontrol
Venus Remedies gets nod to sell generic antibiotic in Spain
3 months ago•The Hindu
Venus Remedies hits 5% upper circuit on drug approval in Spain
3 months ago•Moneycontrol
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 8.59%, vs industry avg of 8.45%
Constant Market Share
Over the last 5 years, market share stayed at 0.18%